BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2000 related articles for article (PubMed ID: 8165017)

  • 1. Immunohistochemical analysis of cutaneous malignant melanoma: comparison of S-100 protein, HMB-45 monoclonal antibody and NKI/C3 monoclonal antibody.
    Fernando SS; Johnson S; Bäte J
    Pathology; 1994 Jan; 26(1):16-9. PubMed ID: 8165017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HMB-45, S-100, NK1/C3, and MART-1 in metastatic melanoma.
    Zubovits J; Buzney E; Yu L; Duncan LM
    Hum Pathol; 2004 Feb; 35(2):217-23. PubMed ID: 14991540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical study of melanocytic differentiation antigens in cutaneous malignant melanoma. A comparison of six commercial antibodies and one non-commercial antibody in nodular melanoma, superficially spreading melanoma and lentigo maligna melanoma.
    Kocan P; Jurkovic I; Böör A; Dudríková K; Krajcár R; Benický M; Kromydaki A
    Cesk Patol; 2004 Apr; 40(2):50-6. PubMed ID: 15233017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The immunohistochemical identification of human oral mucosal melanocytes.
    Barrett AW; Raja AM
    Arch Oral Biol; 1997 Jan; 42(1):77-81. PubMed ID: 9134118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epithelial markers in malignant melanoma. A study of primary lesions and their metastases.
    Ben-Izhak O; Stark P; Levy R; Bergman R; Lichtig C
    Am J Dermatopathol; 1994 Jun; 16(3):241-6. PubMed ID: 7524376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal angiomyolipoma: further immunophenotypic characterization of an expanding morphologic spectrum.
    Stone CH; Lee MW; Amin MB; Yaziji H; Gown AM; Ro JY; Têtu B; Paraf F; Zarbo RJ
    Arch Pathol Lab Med; 2001 Jun; 125(6):751-8. PubMed ID: 11371226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative distribution of S-100 protein and antigen HMB-45 in various types of melanomas and naevi.
    Mirecka J; Korabiowska M; Schauer A
    Pol J Pathol; 1995; 46(3):167-72. PubMed ID: 7496736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Contribution of monoclonal antibody HMB45 in the histopathologic diagnosis of melanoma].
    Pluot M; Joundi A; Grosshans E
    Ann Dermatol Venereol; 1990; 117(10):691-9. PubMed ID: 1705764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recognition of malignant melanoma by monoclonal antibody HMB-45. An immunohistochemical study of 200 paraffin-embedded cutaneous tumors.
    Wick MR; Swanson PE; Rocamora A
    J Cutan Pathol; 1988 Aug; 15(4):201-7. PubMed ID: 3053811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical diagnosis of malignant melanoma of the conjunctiva and uvea: comparison of the novel antibody against melan-A with S100 protein and HMB-45.
    Heegaard S; Jensen OA; Prause JU
    Melanoma Res; 2000 Aug; 10(4):350-4. PubMed ID: 10985669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The usefulness of tyrosinase in the immunohistochemical assessment of melanocytic lesions: a comparison of the novel T311 antibody (anti-tyrosinase) with S-100, HMB45, and A103 (anti-melan-A).
    Clarkson KS; Sturdgess IC; Molyneux AJ
    J Clin Pathol; 2001 Mar; 54(3):196-200. PubMed ID: 11253130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metastatic uveal melanoma. A morphologic and immunohistochemical analysis.
    Luyten GP; Mooy CM; Post J; Jensen OA; Luider TM; de Jong PT
    Cancer; 1996 Nov; 78(9):1967-71. PubMed ID: 8909318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary mucosal malignant melanoma: an immunohistochemical study of 12 cases with comparison to cutaneous and metastatic melanomas.
    Fitzgibbons PL; Chaurushiya PS; Nichols PW; Chandrasoma PT; Martin SE
    Hum Pathol; 1989 Mar; 20(3):269-72. PubMed ID: 2722176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of immunohistochemical staining of the novel antibody melan-A with S100 protein and HMB-45 in malignant melanoma and melanoma variants.
    Blessing K; Sanders DS; Grant JJ
    Histopathology; 1998 Feb; 32(2):139-46. PubMed ID: 9543670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microphthalmia transcription factor: a sensitive and specific marker for malignant melanoma in cytologic specimens.
    Dorvault CC; Weilbaecher KN; Yee H; Fisher DE; Chiriboga LA; Xu Y; Chhieng DC
    Cancer; 2001 Oct; 93(5):337-43. PubMed ID: 11668469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acral lentiginous melanoma: an immunohistochemical study of 20 cases.
    Kim YC; Lee MG; Choe SW; Lee MC; Chung HG; Cho SH
    Int J Dermatol; 2003 Feb; 42(2):123-9. PubMed ID: 12709000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical localization of the Ca2+ binding S100 proteins in normal human skin and melanocytic lesions.
    Böni R; Burg G; Doguoglu A; Ilg EC; Schäfer BW; Müller B; Heizmann CW
    Br J Dermatol; 1997 Jul; 137(1):39-43. PubMed ID: 9274623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of melanocytic neoplasms: application of a pan-melanoma antibody cocktail.
    Orchard G
    Br J Biomed Sci; 2002; 59(4):196-202. PubMed ID: 12572952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of gp100, MART-1, tyrosinase, and S100 in paraffin-embedded primary melanomas and locoregional, lymph node, and visceral metastases: implications for diagnosis and immunotherapy. A study conducted by the EORTC Melanoma Cooperative Group.
    de Vries TJ; Smeets M; de Graaf R; Hou-Jensen K; Bröcker EB; Renard N; Eggermont AM; van Muijen GN; Ruiter DJ
    J Pathol; 2001 Jan; 193(1):13-20. PubMed ID: 11169510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melanoma-associated antigen recognized by T cells (MART-1): the advent of a preferred immunocytochemical antibody for the diagnosis of metastatic malignant melanoma with fine-needle aspiration.
    Fetsch PA; Marincola FM; Filie A; Hijazi YM; Kleiner DE; Abati A
    Cancer; 1999 Feb; 87(1):37-42. PubMed ID: 10096358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 100.